Epidemiology of strongyloidiasis determined by parasite-specific IgG detections by enzyme-linked immunosorbent assay on urine samples using Strongyloides stercoralis, S. ratti and recombinant protein (NIE) as antigens in Northeast Thailand

PLoS One. 2023 Apr 12;18(4):e0284305. doi: 10.1371/journal.pone.0284305. eCollection 2023.

Abstract

Detection of anti-Strongyloides IgG in urine by enzyme-linked immunosorbent assay (ELISA) for diagnosis of strongyloidiasis reportedly has comparable performance to conventional serum assays. Initial comparisons of urine assays using commercial ELISA kits designated for serology have shown its diagnostic potential but sub-optimal accuracy. In the present study, we optimized urine ELISA protocols based on different antigen types and evaluated their accuracies in determining the epidemiology of strongyloidiasis in Northeast Thailand. Paired urine and fecal samples of 966 individuals from the study community were collected for three consecutive days and tested for strongyloidiasis. We compared three ELISA protocols using different antigens including crude S. stercoralis antigen (Ss-ELISA), crude S. ratti antigen (Sr-ELISA) and recombinant NIE antigen (NIE-ELISA) and fecal examination by agar plate-culture (APCT) technique and formalin-ethyl acetate concentration technique (FECT). The optimized ELISA protocols using three different antigen sources yielded significantly higher prevalence rates of strongyloidiasis (58.9-65.1%) than those by fecal examination methods (19.7%). The prevalence of strongyloidiasis determined by ELISA protocols significantly increased with age (p value < 0.0001) and males had higher prevalence than females (p value < 0.0001). Diagnostic agreements between ELISA protocols were moderate (κ = 0.461-0.586) and the agreement between each ELISA protocol and fecal examinations were slight (κ = 0.139-0.210). The results obtained by urine ELISA protocols using three different antigens showed comparable diagnostic performances, provided further supports for the utility of urine as an alternative clinical specimen for diagnosis of strongyloidiasis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Helminth
  • Antigens, Helminth
  • Enzyme-Linked Immunosorbent Assay / methods
  • Feces
  • Female
  • Humans
  • Immunoglobulin G
  • Male
  • Parasites*
  • Recombinant Proteins
  • Sensitivity and Specificity
  • Strongyloides stercoralis*
  • Strongyloidiasis* / diagnosis
  • Strongyloidiasis* / epidemiology
  • Thailand / epidemiology

Substances

  • Antibodies, Helminth
  • Antigens, Helminth
  • Recombinant Proteins
  • Immunoglobulin G

Grants and funding

This work described here was supported by the Faculty of Medicine, Khon Kaen University, Thailand (Grant Number IN60242) to CE. SR is supported by the Royal Golden Jubilee Ph.D. Program (grant no. PHD/0017/2557). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the Royal Golden Jubilee Ph.D. Program. The work described here was partly supported by the Cholangiocarcinoma Research Institute, Khon Kaen University, and Fluke-Free Thailand, National Research Council of Thailand. PS is supported by National Science, Research and Innovation Fund (NSRF) under the Basic Research Fund of Khon Kaen University through Cholangiocarcinoma Research Institute (CARI-BRF64-50). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.